Application of Membrane Science to Remove Endocrine Disrupting Compounds (EDCs) and Pharmaceutically Active Compounds (PhACs): A Review

Abstract:

To date, membrane technology is of great concern while conventional processes are not able to fulfill prosperous separation. The presence of EDCs in the environment indicates that conventional treatment plants (CTPs) may have limited capability to remove these compounds. Membrane process such as membrane bioreactors (MBRs), nanofiltration (NF) and reverse osmosis (RO) can produce high quality effluents suitable for reuse applications. Membrane bioreactor (MBR) technology is a promising method for water and wastewater treatment because of its ability to produce high-quality effluent that meets water quality regulations. This paper aimed to provide a review of recent research on feasibility of membrane technology such as MBR, NF and RO and also their application to remove EDCs and PhACs from aqueous solution which are highly harmful and toxic. The major factors which exert influence on the separation of these organic micropollutants have been also studied.

• Periodical: Advanced Materials Research (Volume 893)
• Pages: 500-503
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.893.500
• Online since: February 2014
• Authors: Elnaz Halakoo*, Javid Adabi, Sara Aalinezhad, Alireza Layeghi Moghaddam, Alireza Rahimi
• Keywords: Membrane Bioreactor, Nanofiltration, Organic Micro-Pollutant, Reverse Osmosis

References

[1] L. Braeken, B. Van der Bruggen, Feasibility of nanofiltration for the removal of endocrine disrupting compounds, Desalination. 240 (2009) 127–131.

DOI: 10.1016/j.desal.2007.11.069

[2] K. Kimura, S. Toshima, G. Amy, Y. Watanabe, Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes, J. Membr. Sci. 245 (2004) 71–78.

DOI: 10.1016/j.memsci.2004.07.018

[3] K. Kimura, G. Amy, J.E. Drewes, T. Heberer, T. -U. Kim, Y. Watanabe, Rejection of organic micropollutants (disinfection by-products, endocrine disrupting compounds, and pharmaceutically active compounds) by NF/RO membranes, J. Membr. Sci. 227 (2003).

DOI: 10.1016/j.memsci.2003.09.005

[4] S. Judd, The MBR Book: Principles and Applications of Membrane Bioreactors in Water and Wastewater Treatment, first ed., Great Britain, 2006, p.22.

[5] A. Ben-David, R. Bernstein, Y. Oren, S. Belfer, C. Dosoretz, V. Freger, Facile surface modification of nanofiltration membranes to target the removal of endocrine-disrupting compounds, J. Membr. Sci., 357 (2010) 152-159.

DOI: 10.1016/j.memsci.2010.04.015

[6] Z. -h. Liu, Y. Kanjo, S. Mizutani, Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment — physical means, biodegradation, and chemical advanced oxidation: A review, Sci. Total Environ. 407 (2009) 731-748.

DOI: 10.1016/j.scitotenv.2008.08.039

[7] Y. Yoon, P. Westerhoff, S.A. Snyder, E.C. Wert, J. Yoon, Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes, Desalination, 202 (2007) 16-23.

DOI: 10.1016/j.desal.2005.12.033

[8] A. Shahtalebi, M.H. Sarrafzadeh, M. M. Montazer Rahmati, Application of nanofiltration membrane in the separation of amoxicillin from pharmaceutical wastewater, Iran. J. Environ. Health. Sci. Eng. (2011) 109-116.

[9] S. Xia, J. Guo, R. Wang, Performance of a pilot-scale submerged membrane bioreactor (MBR) in treating bathing wastewater, Bioresour. Technol. 99 (2008) 6834-6843.

DOI: 10.1016/j.biortech.2008.01.044

[10] Y. Zhou, X. Huang, H. Zhou, J. Chen, W. Xue , Removal of typical endocrine disrupting chemicals by membrane bioreactor: in comparison with sequencing batch reactor, Water. Sci. Technol. 64 (2011) 2096-2102.

DOI: 10.2166/wst.2011.426

[11] A. J. Spring, D. M. Bagley, R. C. Andrews, S. Lemanik, P. Yang, Removal of endocrine disrupting compounds using a membrane bioreactor and disinfection, J. Environ. Eng. Sci. 6 (2007) 131-137.

DOI: 10.1139/s06-049

[12] F. Zaviska, P. Drogui, A. Grasmick, A. Azais, M. Heran, Nanofiltration membrane bioreactor for removing pharmaceutical compounds, J. Membr. Sci. 429 (2013) 121 –129.

DOI: 10.1016/j.memsci.2012.11.022